Company Accounts and Tax Online 08555320 Board of Directors 1.7.24 30.6.25 30.6.25 No description of principal activity false iso4217:GBP xbrli:pure 08555320 2023-07-01 2024-06-30 08555320 2025-06-30 08555320 2024-07-01 2025-06-30 08555320 2024-06-30 08555320 countries:EnglandWales 2024-07-01 2025-06-30 08555320 curr:PoundSterling 2024-07-01 2025-06-30 08555320 uk-bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 08555320 uk-bus:Micro-entities 2024-07-01 2025-06-30 08555320 uk-bus:AuditExempt-NoAccountantsReport 2024-07-01 2025-06-30 08555320 uk-bus:FullAccounts 2024-07-01 2025-06-30 08555320 uk-bus:RegisteredOffice 2024-07-01 2025-06-30 08555320 uk-bus:Director1 2024-07-01 2025-06-30 08555320 uk-bus:Director1 2024-07-01 08555320 uk-bus:Director1 2025-06-30 08555320 core:AfterOneYear 2025-06-30 08555320 core:AfterOneYear 2024-06-30 08555320 core:WithinOneYear 2025-06-30 08555320 core:WithinOneYear 2024-06-30 08555320 core:WithinOneYear 2024-07-01 2025-06-30 08555320 core:AfterOneYear 2025-06-30 08555320 core:AfterOneYear 2024-06-30 08555320 core:AfterOneYear 2024-07-01 2025-06-30 08555320 core:ShareCapital 2025-06-30 08555320 core:ShareCapital 2024-06-30 08555320 core:RevaluationReserve 2025-06-30 08555320 core:RevaluationReserve 2024-06-30 08555320 core:RetainedEarningsAccumulatedLosses 2025-06-30 08555320 core:RetainedEarningsAccumulatedLosses 2024-06-30 08555320 1 2024-07-01 2025-06-30

# RX CLIN RESEARCH LIMITED

## Company Registration Number:
08555320 (England and Wales)

## Unaudited micro entity accounts for the year ended 30 June 2025

## Period of accounts

## Start date: 01 July 2024

## End date: 30 June 2025

# RX CLIN RESEARCH LIMITED

## Contents of the Financial Statements

for the Period Ended 30 June 2025

Company Information - 3 |
Report of the Directors - 4 |
Profit and Loss Account - 5 |
Balance sheet - 6 |
Footnotes to the Balance Sheet - 8 |

# RX CLIN RESEARCH LIMITED

## Company Information

for the Period Ended 30 June 2025

Director: |  | Xiaohui Ren
Registered office: |  | 14 Mccabe Place Headington Oxford Oxfordshire OX3 0LQ
Company Registration Number: |  | 08555320 (England and Wales)

# RX CLIN RESEARCH LIMITED

## Directors' Report Period Ended 30 June 2025

The directors present their report with the financial statements of the company for the period ended 30 June 2025

Directors

The directors shown below have held office during the whole of the period from 01 July 2024 to 30 June 2025
Xiaohui Ren

This report was approved by the board of directors on 30 March 2026
And Signed On Behalf Of The Board By:

Name: Xiaohui Ren
Status: Director

# RX CLIN RESEARCH LIMITED

## Profit and Loss Account

for the Period Ended 30 June 2025

| 2025 £ | 2024 £
--- | --- | ---
Income from coronavirus (COVID-19) business support grants | 0 | 0
Other Income | 1,658 | 1,980
Cost of Materials | ( 0 ) | ( 0 )
Staff Costs | ( 0 ) | ( 0 )
Depreciation and Writeoffs | ( 0 ) | ( 0 )
Other charges | ( 3,664 ) | ( 5,002 )
Tax on Profit | ( 0 ) | ( 0 )
Profit or (Loss) for Period | ( 2,006 ) | ( 3,022 )

# RX CLIN RESEARCH LIMITED

## Balance sheet

As at 30 June 2025

| 2025 £ | 2024 £
--- | --- | ---
Called up share capital not paid: | 0 | 0
Fixed Assets: | 0 | 0
Current assets: | 157,353 | 160,329
Prepayments and accrued income: | 0 | 0
Creditors: amounts falling due within one year: | ( 0 ) | ( 0 )
Net current assets (liabilities): | 157,353 | 160,329
Total assets less current liabilities: | 157,353 | 160,329
Total net assets (liabilities): | 157,353 | 160,329
Capital and reserves: | 157,353 | 160,329

# RX CLIN RESEARCH LIMITED

## Balance sheet continued

For the year ending 30 June 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 30 March 2026
And Signed On Behalf Of The Board By:

Name: Xiaohui Ren
Status: Director

The notes form part of these financial statements

# RX CLIN RESEARCH LIMITED

## Footnotes to the Financial Statements

for the Period Ended 30 June 2025

- ## 1. Employee Information

  Average number of employees: 0

# RX CLIN RESEARCH LIMITED

## Footnotes to the Financial Statements

for the Period Ended 30 June 2025

- ## 2. Off balance sheet disclosure

  No